# Nifedipine

## Alat 10mg

| TAH Drug Code      | [OALA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OALA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Angina (Chest Pain): Includes vasospastic angina and chronic stable angina. Hypertension: Using short-acting nifedipine for hypertension may cause rapid blood pressure drop and reflex tachycardia， leading to cardiovascular complications. Short-acting nifedipine for hypertension should only be used when no other suitable therapy is available， and sublingual nifedipine capsules are not recommended.                                                                                                                                                                                                                           |
| Dosing             | HTN， angina 10-20mg TID， maximum 180mg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | cardiogenic shock concomitant use of strong CYP450 inducers， including rifampin hypersensitivity to NIFEdipine or any component                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Initially mild & transient vasodilatation， hypotension， rarely GI， skin & other reactions. Very rarely: transient visual change; chest discomfort (if relation established， discontinue therapy). Extremely rare: on prolonged use gingival hyperplasia， gynaecomastia (both regressing on discontinuation); hepatobiliary disorders. Cardiovascular: Hypotension (up to 5% )， Palpitations (up to 7% )， Peripheral edema (7% to 29% ) Dermatologic: Flushing (4% to 25%) Gastrointestinal: Nausea (up to 10% ) Neurologic: Dizziness (4% to 10% )， Headache (19% to 23%) Psychiatric: Feeling nervous Respiratory: Cough， Dyspnea |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nifedipine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## Nifedipine S.R.F.C. 30mg

| TAH Drug Code      | [ONIF](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONIF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Angina (Chest Pain): Includes vasospastic angina and chronic stable angina. Hypertension.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | angina: 30mg QD. HTN: 30mg QD up to 120mg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | cardiogenic shock concomitant use of strong CYP450 inducers， including rifampin hypersensitivity to NIFEdipine or any component of the tablet                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Initially mild & transient vasodilatation， hypotension， rarely GI， skin & other reactions. Very rarely: transient visual change; chest discomfort (if relation established， discontinue therapy). Extremely rare: on prolonged use gingival hyperplasia， gynaecomastia (both regressing on discontinuation); hepatobiliary disorders. Cardiovascular: Hypotension (up to 5% )， Palpitations (up to 7% )， Peripheral edema (7% to 29% ) Dermatologic: Flushing (4% to 25%) Gastrointestinal: Nausea (up to 10% ) Neurologic: Dizziness (4% to 10% )， Headache (19% to 23%) Psychiatric: Feeling nervous Respiratory: Cough， Dyspnea |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nifedipine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

